Akebia Therapeutics (AKBA) Tax Rate (2018 - 2026)

Akebia Therapeutics' (AKBA) quarterly Tax Rate came in at 1.41% in Q1 2026, up 84.29% on a QoQ basis from 8.98% in Q4 2025.

Akebia Therapeutics (AKBA) Tax Rate (2018 - 2026) Analysis & Trends

Akebia Therapeutics (AKBA) has 4 years of Tax Rate data on file, last reported at 1.41% in Q1 2026.

On a quarterly basis, Tax Rate changed N/A year-over-year to 1.41% in Q1 2026; TTM through Mar 2026 was 9.33%, a N/A change from a year earlier, with the FY2025 full-year figure at 43.64%, changed N/A from the prior year.
Tax Rate for Q1 2026 stood at 1.41%, up from 8.98% in the prior quarter.
Over the last five years, Tax Rate for AKBA reached as high as 53.25% in Q3 2025 and fell as low as 8.98% in Q4 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Haleon	88.07 Bn	86.20 Bn	-	-
2	Teva Pharmaceutical Industries	35.75 Bn	32.01 Bn	1.97 Bn	15.33
3	Zoetis	31.84 Bn	29.90 Bn	1.62 Bn	20.71
4	Takeda Pharmaceutical	27.18 Bn	23.12 Bn	4.39 Bn	-23.33
5	United Therapeutics	23.09 Bn	20.93 Bn	648.10 Mn	13.63
6	RedHill Biopharma	21.32 Bn	21.32 Bn	-	-
7	Viatris	19.96 Bn	18.16 Bn	1.16 Bn	171.33
8	Neurocrine Biosciences	17.66 Bn	16.34 Bn	800.70 Mn	19.81
9	Elanco Animal Health	12.44 Bn	12.02 Bn	785.00 Mn	34.48
10	Akebia Therapeutics	328.47 Mn	165.87 Mn	41.25 Mn	-1.41

Historic Data

Download Data

Date	Value
Mar 31, 2026	-1.41%
Mar 31, 2026	-1.41%
Mar 31, 2026	-1.41%
Dec 31, 2025	-8.98%
Dec 31, 2025	-8.98%
Dec 31, 2025	-8.98%
Sep 30, 2025	53.25%
Sep 30, 2025	53.25%
Sep 30, 2025	53.25%
Dec 31, 2019	6.86%
Dec 31, 2019	6.86%
Dec 31, 2019	6.86%
Sep 30, 2019	2.29%
Sep 30, 2019	2.29%
Sep 30, 2019	2.29%
Jun 30, 2019	1.43%
Jun 30, 2019	1.43%
Jun 30, 2019	1.43%
Mar 31, 2019	3.67%
Mar 31, 2019	3.67%